| Rebecca Elaine Remmers, MD | |
|
8040 Villa Park Dr, Richmond, VA 23228-6507 | |
| (804) 266-7777 | |
| (804) 266-6853 |
| Full Name | Rebecca Elaine Remmers |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 8040 Villa Park Dr, Richmond, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285843730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101053126 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Elaine Remmers, MD 5203 Watercrest Pl, Midlothian, VA 23112-2563 Ph: () - | Rebecca Elaine Remmers, MD 8040 Villa Park Dr, Richmond, VA 23228-6507 Ph: (804) 266-7777 |
News Archive
"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.
A Ludwig Cancer Research study published online September 5th in Nature Immunology illuminates a key requirement for the function of regulatory T cells—immune cells that play a critical role in many biological processes, from suppressing inflammation and deadly autoimmunity to helping tumors evade immune attack.
Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the second quarter of 2010 were approximately DKK 73 million (approximately USD 12 million). Arzerra second quarter net sales in the U.S. and the rest of the world were approximately DKK 64 million (approximately USD 10.5 million) and approximately DKK 9 million (approximately USD 1.5 million) respectively.
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
The new Loyola Center for Cancer Care & Research at Palos Community Hospital is offering cancer patients academic level care close to home.
› Verified 2 days ago
Dr. Paul Weisz-carrington, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1201 Broad Rock Blvd, 113, Richmond, VA 23249 Phone: 804-794-9396 | |
Dr. Beth Barton Hewitt, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Elaine Lizabeth Flanders, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Jennifer A Daniel-johnson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 219 N 28th St, Richmond, VA 23223 Phone: 206-552-4889 | |
Dr. Harold Paul Dunn, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Susan D Roseff, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall Street, Pathology, Richmond, VA 23298 Phone: 804-828-9746 Fax: 804-828-9749 | |
Dr. Jonathan M Ben-ezra, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall Street, Pathology, Richmond, VA 23298 Phone: 804-828-0902 Fax: 804-828-2812 |